Servier
From Wikipedia, the free encyclopedia
| Servier | |
| Image:Logo-servier.gif | |
| Type | The leading French independent pharmaceutical company |
|---|---|
| Founded | |
| Headquarters | Neuilly-sur-Seine, France |
| Key people | |
| Industry | Pharmaceutical |
| Products | Reference products for diseases of major importance |
| Revenue | |
| Operating income | |
| Net income | |
| Employees | 17 500 employees worldwide, including 2500 in Research and Development |
| Slogan | Life through Discovery |
| Website | www.servier.com |
[edit] Key figures and data for 2005
- Key figures and data for 2005
- Leading French independent pharmaceutical company
- Second French pharmaceutical company worldwide
- SERVIER is established in 140 countries
- 80% of SERVIER's sales are achieved internationally
- Consolidated turnover for the 2004/2005 financial year: €2.8 billion
- Almost 25% of SERVIER’s turnover is invested in Research and Development (average over the last 5 years)
- Worldwide workforce of 17 500 including 2500 in Research and Development
- 500 million drug boxes were produced for patients by the production sites in 2005
- Overall, over 100 drug forms are produced for the French market and over 2500 for the international market
- The SERVIER Clinical Support Unit in Gidy (near Orleans) is the largest unit of its kind in Europe for the production of drugs for clinical trials
[edit] Product portfolio
500 million boxes of drugs were produced by SERVIER's production sites in 2005.
Overall, more than 100 different drug forms have been produced for the French market and over 2500 for the international market.
- SERVIER DRUGS IN THE WORLD
| ARCALION | NATRILIX SR |
| ARTEX | PNEUMOREL |
| COVERSYL | PRETERAX - BIPRETERAX |
| DAFLON 500 | PROCORALAN |
| DIAMICRON MR | PROTELOS |
| DUXIL | PSEUDOPHAGE |
| GLUCIDORAL | STABLON |
| HYPERIUM | TRIVASTAL RETARD |
| LOCABIOTAL | VASTAREL MR |
| MEDIAXAL | VECTARION |
| MUPHORAN | VITATHION |
